Cases of highly contagious and often drug-resistant fungal infections are on the rise in the U.S., according to a new study. Researchers report that Candida auris infections increased dramatically between 2019 and 2021, with the number of drug-resistant cases tripling each year. Candida auris is a yeast-type fungus that can enter the bloodstream, causing severe illness and death, particularly in healthcare settings.
A review of the most recent data showed a 44% increase in cases in 2019, a 59% increase in 2020, and a 95% jump in 2021. The results also revealed a concerning rise in the number of infections resistant to first-line treatments. Study authors suggest that this upward trend may be related to the strain COVID-19 placed on healthcare systems, including staff and equipment shortages. They emphasize that improved detection and infection control practices are urgently needed to prevent the spread of Candida auris.
